Skip to main content

Miromatrix Medical Inc.

MIRODelisted Dec 13, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001527096

Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Miromatrix Medical Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of MIRO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders2119−2
Shares3.36M3.16M−201.7K (−6.0%)
Value$39.1M$22.0M−$17.2M (−43.9%)

New holders (6)

Institutions that held Miromatrix Medical Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to MIRO in Q3 2021
InstitutionSharesValue% of portfolio
BlackRock Inc.14,786$103.0K0.00%
Geode Capital Management, LLC10,203$71.0K0.00%
Royal Bank of Canada2,000$14.0K0.00%
Tower Research Capital LLC (TRC)1,309$9.00K0.00%
UBS Group AG125$1.00K0.00%
Wells Fargo & Company29$00.00%

Sold out (8)

Institutions that held Miromatrix Medical Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of MIRO in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Gilder Gagnon Howe & Co LLC160,000$1.86M
MYDA Advisors LLC30,000$350.0K
Maven Securities LTD19,365$242.0K
Virtu Financial LLC13,467$157.0K
Aristides Capital LLC10,500$122.0K
Essex Investment Management Co LLC2,500$29.0K
Morgan Stanley1,126$13.0K
FNY Investment Advisers, LLC900$10.0K